Stock data
Vor Biopharma Inc. (VOR)
Vor Biopharma Inc. (VOR) reported net income of -US$695.98M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$371.64M | -US$695.98M | — |
| 2024 | — | — | -US$121.19M | -US$116.91M | — |
| 2023 | — | — | -US$126.04M | -US$117.86M | — |
| 2022 | — | — | -US$93.42M | -US$92.09M | — |
| 2021 | — | — | -US$69.02M | -US$68.90M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$62.81M | — |
| 2026-03-31 | — | -US$219.58M | — |
| 2025-12-31 | — | US$1.72B | — |
| 2025-09-30 | — | -US$812.68M | — |
| 2025-06-30 | — | -US$1.57B | — |
| 2025-03-31 | — | -US$32.49M | — |
| 2024-12-31 | — | -US$30.71M | — |
| 2024-09-30 | — | -US$27.56M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.